However, in T2D, targeted metabolic inhibition using nutritional and/or pharmacological compounds could prevent insulin resistance and improve insulin sensitivity in prediabetic and diabetic animal models and in diabetic patients. This evidence concerns the gene INS and Insulin resistance.